Back
Nektar Therapeutics 10K Form
Sell
15
NKTR
Nektar Therapeutics
Last Price:
$0.51
Seasonality Move:
-1.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-10 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2023-11-08 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2023-08-09 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2023-05-10 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2022-11-04 | 10Q | NKTR/Nektar Therapeutics Quarterly |
| 2022-08-05 | 10Q | NKTR/Nektar Therapeutics Quarterly |
Receive NKTR News And Ratings
See the #1 stock for the next 7 days that we like better than NKTR
NKTR Financial Statistics
Sales & Book Value
| Annual Sales: | $98.4M |
|---|---|
| Cash Flow: | $-46.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.33 |
| Price / Book: | 1.51 |
Profitability
| EPS (TTM): | -0.59000 |
|---|---|
| Net Income (TTM): | $-119M |
| Gross Margin: | $67.7M |
| Return on Equity: | -133.07% |
| Return on Assets: | -34.01% |
Nektar Therapeutics Earnings Forecast
Key Nektar Therapeutics Financial Ratios
-
The Gross Profit Margin over the past 31 years for NKTR is 68.82%.
-
The Selling, General & Administrative Expenses for NKTR have been equal to 77.98% of Gross Profit Margin.
-
The Research & Development expenses have been 122.84% of Revenue.
-
The Net Earning history of NKTR is -120.86% of Total Revenues.
-
Per Share Earnings over the last 31 years have been positive in 15 years.
Nektar Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NKTR |
| CUSIP: | 640268 |
| Website: | nektar.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.26 |
| Quick Ratio: | 4.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NKTR Technical Analysis vs Fundamental Analysis
Sell
15
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy or a Sell?
-
Nektar Therapeutics stock is rated a SellThe current Nektar Therapeutics [NKTR] share price is $0.49. The Score for NKTR is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.